HYPONATREMIA IN COVID-19 PATIENTS

Completed

• Conditions: Hyponatremia; Covid19; Corona Virus Infection

• Registration Number: NCT04493268
• Lead Sponsor: Hospital Nacional Profesor Alejandro Posadas

Brief Summary

SYSTEMIC INFLAMMATION HAS BEEN ASSOCIATED WITH SEVERE COVID-19. HYPONATREMIA CAN RESULT FROM INFLAMMATION DUE TO NON-OSMOTIC STIMULI FOR VASOPRESSIN PRODUCTION. IN THIS PROSPECTIVE COHORT STUDY WE ANALIZED DATA FROM PATIENTS WITH COVID-19 AND THE ASOCIATION WITH HYPONATREMIA AND CLINICAL OUTCOMES.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-03-07
• Status Verified: 2020-07
• Primary Completion: 2020-07-20
• Study Completion: 2020-07-21
• Study First Submitted: 2020-07-28
• Study First Submitted QC: 2020-07-29
• Last Update Submitted: 2020-07-29
• Study First Posted: 2020-07-30
• Last Update Posted: 2020-07-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

• PATIENTS WITH SARS-CoV-2 INFECTION CONFIRMED BY PCR OF NASOPHARYNGEAL SWABS.

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
MORTALITY	30 DAYS	HYPONATREMIA AND MORTALITY

Secondary Outcome Measures

Name	Time	Method
ICU HOSPITALIZATION	30 DAYS	HYPONATREMIA AND ICU HOSPITALIZATION

Trial Locations

Locations (1)

Hospital Posadas; 🇦🇷 Buenos Aires, Argentina